| Literature DB >> 31217317 |
Eugene Yu-Chuan Kang1,2, Chiun-Ho Hou1,2, Yhu-Chering Huang2,3, Ching-Hsi Hsiao1,2.
Abstract
OBJECTIVE: To explored 6-month longitudinal changes in conjunctival colonisation and antibiotic resistance profiles of coagulase-negative Staphylococcus (CNS) after cataract surgery with 1 month tobramycin treatment.Entities:
Keywords: antibiotic susceptibility; cataract surgery; coagulase-negativeStaphylococcus; colonization
Mesh:
Substances:
Year: 2019 PMID: 31217317 PMCID: PMC6588994 DOI: 10.1136/bmjopen-2018-027036
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
The demographic characteristics the patients classified by conjunctiva coagulase-negative Staphylococcus (CNS) colonisation at baseline
| CNS colonisation in either eye | ||||
| Variable | Total (n=128) | No (n=97) | Yes (n=31) | P |
| Male | 60 (46.9) | 45 (46.4) | 15 (48.4) | >0.99 |
| Age (year, mean±SD) | 68.3±10.7 | 67.5±10.8 | 70.5±9.9 | 0.17 |
| Hospitalisation in 1 year | 30 (23.4) | 24 (24.7) | 6 (19.4) | 0.63 |
| ESRD on dialysis | 6 (4.7) | 6 (6.2) | 0 (0.0) | 0.34 |
| Operation in previous 6 months | 30 (23.4) | 27 (27.8) | 4 (12.9) | 0.15 |
| Lived with child <5 years | 27 (21.1) | 23 (23.7) | 4 (12.9) | 0.31 |
| Skin disease | 14 (10.9) | 10 (10.3) | 4 (12.9) | 0.74 |
| Liver disease | 8 (6.3) | 7 (7.2) | 1 (3.2) | 0.68 |
| Diabetes mellitus | 33 (25.8) | 22 (22.7) | 11 (35.5) | 0.16 |
| Heart disease | 17 (13.3) | 12 (12.4) | 5 (16.1) | 0.56 |
| Chronic kidney disease | 8 (6.3) | 5 (5.2) | 3 (9.7) | 0.40 |
| Hypertension | 66 (51.6) | 47 (48.5) | 19 (61.3) | 0.22 |
Data were expressed as number and percentage; no patients had a history of using immunosuppressants, alcohol abuse, homelessness, HIV infection or malignancy.
P value was obtained by Fisher’s exact test, except the one for age by t-test.
ESRD, end-stage renal disease.
Figure 1Estimated proportion of total colonisation (A) and coagulase-negative Staphylococcus (CNS) colonisation (B) on operation (OP) and non-OP eyes through 6 month follow-up. *Indicates the Bonferroni-adjusted p<0.10 (unadjusted P<0.017) compared with pre-OP within group. The OP eyes and non-OP eyes were simultaneously estimated in a GLMM analysis. GLMM, generalised linear mixed model.
Figure 2Changes in antibiotic resistance response of coagulase-negative Staphylococcus (CNS) isolated from operation (OP) eyes (A) and non-OP eyes (B). *Indicates the Bonferroni-adjusted p<0.05 (unadjusted p<0.008) compared with pre-OP within group. †Indicates the Bonferroni-adjusted p<0.10 (unadjusted p<0. 017) compared with pre-OP within group. The OP eyes and non-OP eyes were simultaneously estimated in a GLMM analysis. The six antibiotic resistance responses were analysed separately in six GLMMs. GLMM, generalised linear mixed model; TMP-SMX, trimethoprim/sulfamethoxazole.
Percentage of antibiotic resistance of coagulase-negative Staphylococcus (CNS) isolated from operation (OP) eyes and non-OP eyes
| Antibiotic | Pre-OP (n=128) | First month (n=77) | Third month (n=60) | Sixth month (n=49) | ||||
| OP eyes | Non-OP eyes | OP eyes | Non-OP eyes | OP eyes | Non-OP eyes | OP eyes | Non-OP eyes | |
| Clindamycin | 6.7 | 17.4 | 18.8 | 11.8 | 12.5 | 14.3 | 20 | 23.1 |
| Erythromycin | 40 | 30.4 | 31.3 | 41.2 | 37.5 | 42.9 | 30 | 38.5 |
| Oxacillin | 53.3 | 26.1 | 43.8 | 52.9† | 62.5 | 50 | 70 | 69.2‡ |
| Penicillin | 100 | 60.9§ | 93.8 | 88.2 | 100 | 92.9 | 90 | 100 |
| TMP-SMX | 26.7 | 8.7 | 18.8 | 29.4‡ | 25.0 | 35.7‡ | 10 | 7.7 |
| Ciprofloxacin | 20 | 13.0 | 31.3 | 23.5 | 62.5‡ | 28.6 | 30 | 23.1 |
| Gatifloxacin | 20 | 13.0 | 31.3 | 23.5 | 37.5 | 28.6 | 30 | 23.1 |
| Levofloxacin | 20 | 13.0 | 31.3 | 23.5 | 37.5 | 28.6 | 30 | 23.1 |
| Moxifloxacin | 20 | 8.7 | 25.0 | 17.6 | 25.0 | 14.3 | 20 | 15.4 |
| Tobramycin | 46.7 | 47.8 | 81.3‡ | 47.1§ | 87.5† | 64.3 | 70 | 69.2 |
| Teicoplanin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vancomycin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Results were derived from generalised linear mixed model.
*One eye with 2 CNS isolates identified.
†indicates Bonferroni-adjusted p<0.10 (unadjusted p<0. 017) compared with pre-OP within group.
‡indicates Bonferroni-adjusted p<0.05 (unadjusted p<0. 008) compared with pre-OP within group.
§indicates Bonferroni-adjusted p<0. 05 (unadjusted p<0.012) compared with OP eyes within a specific follow-up time.
TMP-SMX, trimethoprim/sulfamethoxazole.